Therefore, additional translational pre-clinical work is needed to further evaluate the potential of [64Cu]Cu-NOTA-denos-Fab in more appropriate clinical models (e.g., humanized mice models or transgenic models) to study the interaction of host- and tumor-derived RANKL in the tumor microenvironment [47]. This evidence concerns the gene TNFSF11 and neoplasm.